Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Moriarty John B Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Moriarty John B (Chief Legal Officer) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 22,297 shares @ $37, valued at $825k
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/18/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2020 4 Moriarty John B (EVP, Ch. Legal Officer & Sec.) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Granted 252,060 options to buy @ $4.824, valued at $1.2M
Granted 161,406 options to buy @ $19, valued at $3.1M
11/18/2020 3 Moriarty John B (EVP, Ch. Legal Officer & Sec.) has filed a Form 3 on Olema Pharmaceuticals, Inc.
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 16,250 shares @ $0
Paid exercise price by delivering 3,544 shares @ $12.89, valued at $45.7k
Granted 65,000 options to buy @ $12.79, valued at $831.4k
03/05/2019 4 Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 4,297 shares @ $33.42, valued at $143.6k
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2018 4 Moriarty John B (EVP, General Counsel) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 125,000 options to buy @ $32.66, valued at $4.1M
03/20/2018 3 Moriarty John B (EVP, General Counsel) has filed a Form 3 on PORTOLA PHARMACEUTICALS INC
02/08/2018 4 Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Sold 2,163 shares @ $115.7, valued at $250.3k
Sold 1,200 shares @ $115.7, valued at $138.8k
Granted 21,489 shares @ $0
Granted 6,500 shares @ $0
02/07/2018 4 Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Sold 1,261 shares @ $117.26, valued at $147.9k
03/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/13/2016 4 Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Sold 1,044 shares @ $118.61, valued at $123.8k
08/10/2016 4 Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Sold 135 shares @ $137.14, valued at $18.5k
06/14/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/01/2016 4 Moriarty John B (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Granted 5,000 shares @ $0
Sold 1,200 shares @ $138.91, valued at $166.7k
Sold 1 shares @ $140.65, valued at $140.7
Granted 31,000 options to buy @ $140.16, valued at $4.3M
02/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/08/2013 4 Moriarty John B (SVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Granted 2,200 shares @ $0
Granted 29,600 options to buy @ $93.83, valued at $2.8M
12/18/2012 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy